Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CervoMed Inc. (CRVO)

CervoMed posts investor presentation on website under Regulation FD disclosure

Neutral Impact 1 of 5 other Written later

CervoMed Inc. filed an 8-K furnishing an investor presentation covering its business, clinical studies, development plans and financial position, posted on its website. The filing contains no financial results, guidance or new figures, so shareholders have no new numbers to assess from the filing itself.

Key points

  • Presentation posted on cervomed.com under Investors – Events and Presentations.
  • Company may use the presentation at investor conferences and meetings, in whole or in part.
  • Filing is furnished under Item 7.01, not deemed filed under Section 18 of the Exchange Act.
  • Filing is signed by William Elder, Chief Financial Officer & General Counsel, dated October 14, 2026.

The filing

CompanyCervoMed Inc. (CRVO)
Form8-K, current report
Filed with the SECOct 14, 2026, 4:05 PM ET
Accession number0001437749-26-032620

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.